Skip to Content

67 Results Found

  • Abstract
  • Open Access
1,589 Views
1 Page

Development of a T7-Independent MARV Minigenome System

  • Bert Vanmechelen,
  • Joren Stroobants,
  • Kurt Vermeire and
  • Piet Maes

Marburg virus (MARV) is the only known pathogenic filovirus that does not belong to the genus Ebolavirus. It causes a severe hemorrhagic fever that is associated with a high mortality rate (>80%). The potential for filoviruses to cause devastating...

  • Article
  • Open Access
10 Citations
3,418 Views
22 Pages

Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs

  • Courtney L. Finch,
  • Thomas H. King,
  • Kendra J. Alfson,
  • Katie A. Albanese,
  • Julianne N. P. Smith,
  • Paul Smock,
  • Jocelyn Jakubik,
  • Yenny Goez-Gazi,
  • Michal Gazi and
  • Rong Xu
  • + 9 authors

15 November 2022

Marburg virus (MARV) is a virus of high human consequence with a case fatality rate of 24–88%. The global health and national security risks posed by Marburg virus disease (MVD) underscore the compelling need for a prophylactic vaccine, but no...

  • Article
  • Open Access
5 Citations
3,079 Views
13 Pages

Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model

  • Kyle L. O’Donnell,
  • Corey W. Henderson,
  • Hanna Anhalt,
  • Joan Fusco,
  • Jesse H. Erasmus,
  • Teresa Lambe and
  • Andrea Marzi

Marburg virus (MARV), a filovirus, was first identified in 1967 in Marburg, Germany, and Belgrade, former Yugoslavia. Since then, MARV has caused sporadic outbreaks of human disease with high case fatality rates in parts of Africa, with the largest o...

  • Article
  • Open Access
1 Citations
2,599 Views
13 Pages

Serological Evidence of Potential Marburg Virus Circulation in Livestock and Dogs in Ghana

  • Theophilus Odoom,
  • Sherry Ama Mawuko Johnson,
  • William Tasiame,
  • Meyir Y. Ziekah,
  • Joseph K. Abuh,
  • Benita Anderson,
  • Fenteng Danso,
  • Richard K. Abbiw,
  • Franklin Y. Nuokpem and
  • Bonto Faburay
  • + 2 authors

22 October 2024

Marburg virus disease (MVD) is a zoonotic hemorrhagic disease with an estimated case fatality rate of up to 88%. Ghana recorded its first human MVD outbreak in June 2022 and although the outbreak was quickly brought under control, the transmission dy...

  • Article
  • Open Access
3 Citations
2,531 Views
14 Pages

Lysosome-Associated Membrane Protein Targeting Strategy Improved Immunogenicity of Glycoprotein-Based DNA Vaccine for Marburg Virus

  • Xiyang Zhang,
  • Yubo Sun,
  • Junqi Zhang,
  • Hengzheng Wei,
  • Jing Wang,
  • Chenchen Hu,
  • Yang Liu,
  • Sirui Cai,
  • Qinghong Yuan and
  • Kun Yang
  • + 4 authors

4 September 2024

Marburg hemorrhagic fever (MHF) is a fatal infectious disease caused by Marburg virus (MARV) infection, and MARV has been identified as a priority pathogen for vaccine development by the WHO. The glycoprotein (GP) of MARV mediates viral adhesion and...

  • Article
  • Open Access
16 Citations
3,902 Views
15 Pages

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease

  • Wenjun Zhu,
  • Guodong Liu,
  • Wenguang Cao,
  • Shihua He,
  • Anders Leung,
  • Ute Ströher,
  • Michael J. Fairchild,
  • Rick Nichols,
  • Joseph Crowell and
  • Logan Banadyga
  • + 1 author

23 June 2022

Marburg virus (MARV) is a negative-sense, single-stranded RNA virus that belongs to the Filoviridae family. Despite having caused numerous outbreaks of severe hemorrhagic fever with high case fatality rates, there are still no clinically approved the...

  • Article
  • Open Access
3 Citations
2,852 Views
9 Pages

Development of an Immunochromatography Assay to Detect Marburg Virus and Ravn Virus

  • Katendi Changula,
  • Masahiro Kajihara,
  • Shino Muramatsu,
  • Koji Hiraoka,
  • Toru Yamaguchi,
  • Yoko Yago,
  • Daisuke Kato,
  • Hiroko Miyamoto,
  • Akina Mori-Kajihara and
  • Ayato Takada
  • + 4 authors

29 November 2023

The recent outbreaks of Marburg virus disease (MVD) in Guinea, Ghana, Equatorial Guinea, and Tanzania, none of which had reported previous outbreaks, imply increasing risks of spillover of the causative viruses, Marburg virus (MARV) and Ravn virus (R...

  • Brief Report
  • Open Access
647 Views
8 Pages

Evaluation of Probenecid Against Filovirus Replication in Vero E6 Cells

  • Kendra Alfson,
  • Ricardo Carrion,
  • Ralph A. Tripp,
  • Chris Cirimotich and
  • David E. Martin

26 December 2025

In human and non-human primates, filoviruses, e.g., Ebolaviruses, cause severe hemorrhagic fever for which there are few therapeutic options. While there are licensed vaccines and therapeutics for Ebola virus disease, there is no approved vaccine or...

  • Article
  • Open Access
11 Citations
3,618 Views
16 Pages

Natural History of Marburg Virus Infection to Support Medical Countermeasure Development

  • Jason E. Comer,
  • Trevor Brasel,
  • Shane Massey,
  • David W. Beasley,
  • Chris M. Cirimotich,
  • Daniel C. Sanford,
  • Ying-Liang Chou,
  • Nancy A. Niemuth,
  • Joseph Novak and
  • Daniel N. Wolfe
  • + 4 authors

18 October 2022

The Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, recognizes that the evaluation of medical countermeasures under th...

  • Article
  • Open Access
6 Citations
3,866 Views
11 Pages

Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies

  • Md Niaz Rahim,
  • Min Wang,
  • Tong Wang,
  • Shihua He,
  • Bryan D. Griffin,
  • Darwyn Kobasa,
  • Ruifu Yang,
  • Zongmin Du and
  • Xiangguo Qiu

14 March 2019

Filoviruses cause lethal hemorrhagic fever in humans. The filovirus nucleoprotein (NP) is expressed in high abundance in infected cells and is essential for virus replication. To generate anti-filovirus monoclonal antibodies (mAbs) against the NP, mi...

  • Article
  • Open Access
1 Citations
1,390 Views
21 Pages

Valorization of a Natural Compound Library in Exploring Potential Marburg Virus VP35 Cofactor Inhibitors via an In Silico Drug Discovery Strategy

  • Mohamed Mouadh Messaoui,
  • Mebarka Ouassaf,
  • Nada Anede,
  • Kannan R. R. Rengasamy,
  • Shafi Ullah Khan and
  • Bader Y. Alhatlani

This study focuses on exploring potential inhibitors of the Marburg virus interferon inhibitory domain protein (MARV-VP35), which is responsible for immune evasion and immunosuppression during viral manifestation. A combination of in silico technique...

  • Article
  • Open Access
2,451 Views
10 Pages

29 July 2022

The cynomolgus monkey (Macaca fascicularis) non-human primate (NHP) is widely used for filovirus vaccine testing. To use limited BSL-4 resources efficiently and minimize NHP usage, Simon’s two-stage design was adapted to screen candidate Ebola...

  • Article
  • Open Access
6 Citations
2,962 Views
11 Pages

Update on the Phylodynamic and Genetic Variability of Marburg Virus

  • Fabio Scarpa,
  • Liliana Bazzani,
  • Marta Giovanetti,
  • Alessandra Ciccozzi,
  • Francesca Benedetti,
  • Davide Zella,
  • Daria Sanna,
  • Marco Casu,
  • Alessandra Borsetti and
  • Massimo Ciccozzi
  • + 3 authors

11 August 2023

The COVID-19 pandemic has not only strained healthcare systems in Africa but has also intensified the impact of emerging and re-emerging diseases. Specifically in Equatorial Guinea, mirroring the situation in other African countries, unique zoonotic...

  • Article
  • Open Access
4 Citations
4,335 Views
24 Pages

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans

  • Alina Tscherne,
  • Georgia Kalodimou,
  • Alexandra Kupke,
  • Cornelius Rohde,
  • Astrid Freudenstein,
  • Sylvia Jany,
  • Satendra Kumar,
  • Gerd Sutter,
  • Verena Krähling and
  • Asisa Volz
  • + 1 author

24 November 2024

Background/Objectives: Marburg virus (MARV) is the etiological agent of Marburg Virus Disease (MVD), a rare but severe hemorrhagic fever disease with high case fatality rates in humans. Smaller outbreaks have frequently been reported in countries in...

  • Article
  • Open Access
37 Citations
7,803 Views
12 Pages

Antibody Responses to Marburg Virus in Egyptian Rousette Bats and Their Role in Protection against Infection

  • Nadia Storm,
  • Petrus Jansen Van Vuren,
  • Wanda Markotter and
  • Janusz T. Paweska

10 February 2018

Egyptian rousette bats (ERBs) are reservoir hosts for the Marburg virus (MARV). The immune dynamics and responses to MARV infection in ERBs are poorly understood, and limited information exists on the role of antibodies in protection of ERBs against...

  • Article
  • Open Access
16 Citations
6,584 Views
14 Pages

Virulence of Marburg Virus Angola Compared to Mt. Elgon (Musoke) in Macaques: A Pooled Survival Analysis

  • Paul W. Blair,
  • Maryam Keshtkar-Jahromi,
  • Kevin J. Psoter,
  • Ronald B. Reisler,
  • Travis K. Warren,
  • Sara C. Johnston,
  • Arthur J. Goff,
  • Lydia G. Downey,
  • Sina Bavari and
  • Anthony P. Cardile

21 November 2018

Angola variant (MARV/Ang) has replaced Mt. Elgon variant Musoke isolate (MARV/MtE-Mus) as the consensus standard variant for Marburg virus research and is regarded as causing a more aggressive phenotype of disease in animal models; however, there is...

  • Article
  • Open Access
21 Citations
7,389 Views
15 Pages

Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)

  • John M. Dye,
  • Kelly L. Warfield,
  • Jay B. Wells,
  • Robert C. Unfer,
  • Sergey Shulenin,
  • Hong Vu,
  • Donald K. Nichols,
  • M. Javad Aman and
  • Sina Bavari

8 April 2016

Marburg virus (MARV) was the first filovirus to be identified following an outbreak of viral hemorrhagic fever disease in Marburg, Germany in 1967. Due to several factors inherent to filoviruses, they are considered a potential bioweapon that could b...

  • Article
  • Open Access
5 Citations
3,089 Views
34 Pages

Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing

  • Elizabeth E. Zumbrun,
  • Carly B. Garvey,
  • Jay B. Wells,
  • Ginger C. Lynn,
  • Sean Van Tongeren,
  • Jesse T. Steffens,
  • Kelly S. Wetzel,
  • Laura M. Gomba,
  • Kristan A. O’Brien and
  • John M. Dye
  • + 19 authors

28 November 2023

Marburg virus (MARV) causes severe disease and high mortality in humans. The objective of this study was to characterize disease manifestations and pathogenesis in cynomolgus macaques exposed to MARV. The results of this natural history study may be...

  • Article
  • Open Access
3 Citations
3,443 Views
19 Pages

25 July 2024

Egyptian rousette bats (ERBs) are implicated as reservoir hosts for Marburg virus (MARV), but natural mechanisms involved in maintenance of MARV in ERB populations remain undefined. A number of hematophagous ectoparasites, including fleas, parasitize...

  • Article
  • Open Access
7 Citations
3,652 Views
25 Pages

4 November 2021

This study aimed to determine the vector competence of bat-associated nycteribiid flies (Eucamsipoda africana) for Marburg virus (MARV) in the Egyptian Rousette Bat (ERB), Rousettus aegyptiacus. In flies fed on subcutaneously infected ERBs and tested...

  • Article
  • Open Access
26 Citations
6,617 Views
16 Pages

Transcriptomics Reveal Antiviral Gene Induction in the Egyptian Rousette Bat Is Antagonized In Vitro by Marburg Virus Infection

  • Catherine E. Arnold,
  • Jonathan C. Guito,
  • Louis A. Altamura,
  • Sean P. Lovett,
  • Elyse R. Nagle,
  • Gustavo F. Palacios,
  • Mariano Sanchez-Lockhart and
  • Jonathan S. Towner

2 November 2018

The Egyptian rousette bat (ERB) is the only known Marburg virus (MARV) reservoir host. ERBs develop a productive MARV infection with low viremia and shedding but no overt disease, suggesting this virus is efficiently controlled by ERB antiviral respo...

  • Article
  • Open Access
9 Citations
3,241 Views
24 Pages

Development of a Well-Characterized Cynomolgus Macaque Model of Marburg Virus Disease for Support of Vaccine and Therapy Development

  • Kendra J. Alfson,
  • Yenny Goez-Gazi,
  • Michal Gazi,
  • Ying-Liang Chou,
  • Nancy A. Niemuth,
  • Marc E. Mattix,
  • Hilary M. Staples,
  • Benjamin Klaffke,
  • Gloria F. Rodriguez and
  • Ricardo Carrion
  • + 8 authors

14 August 2022

Marburg virus (MARV) is a filovirus that can infect humans and nonhuman primates (NHPs), causing severe disease and death. Of the filoviruses, Ebola virus (EBOV) has been the primary target for vaccine and therapeutic development. However, MARV has a...

  • Article
  • Open Access
3 Citations
2,827 Views
17 Pages

14 December 2024

In this review, we investigated the genetic diversity and evolutionary dynamics of the Orthomarburgvirus marburgense species that includes both Marburg virus (MARV) and Ravn virus (RAVV). Using sequence data from natural reservoir hosts and human cas...

  • Article
  • Open Access
3 Citations
2,544 Views
22 Pages

Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques

  • Vidyleison N. Camargos,
  • Shannan L. Rossi,
  • Terry L. Juelich,
  • Jennifer K. Smith,
  • Nikos Vasilakis,
  • Alexander N. Freiberg,
  • Rick Nichols and
  • Joan Fusco

24 July 2024

Filoviruses, like the Marburg (MARV) and Ebola (EBOV) viruses, have caused outbreaks associated with significant hemorrhagic morbidity and high fatality rates. Vaccines offer one of the best countermeasures for fatal infection, but to date only the E...

  • Review
  • Open Access
8 Citations
7,393 Views
14 Pages

Marburg virus (MARV) is one of the deadliest human zoonotic pathogens, historically traced back to Uganda, in East African-cave-dwelling Egyptian fruit bats (Rousettus aegyptiacus), the probable cradle of MARV. Since its first identification in Germa...

  • Article
  • Open Access
13 Citations
4,788 Views
16 Pages

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses

  • Takeshi Saito,
  • Junki Maruyama,
  • Noriyo Nagata,
  • Mao Isono,
  • Kosuke Okuya,
  • Yoshihiro Takadate,
  • Yurie Kida,
  • Hiroko Miyamoto,
  • Akina Mori-Kajihara and
  • Ayato Takada
  • + 4 authors

22 August 2020

Filoviruses, including Ebola virus (EBOV) and Marburg virus (MARV), cause severe hemorrhagic fever in humans and nonhuman primates with high mortality rates. There is no approved therapy against these deadly viruses. Antiviral drug development has be...

  • Review
  • Open Access
5 Citations
3,652 Views
15 Pages

Immunogenicity, Pathogenesis, and Host’s Immuno-Responses to Marburg Virus Infection

  • Emmanuel Edwar Siddig,
  • Nicaise Ndembi,
  • Ayman Ahmed and
  • Claude Mambo Muvunyi

Due to the sudden emergence and burnout nature of Marburg virus (MARV) outbreaks, little is known about MARV’s pathogenicity and immunogenicity. These gaps in knowledge are limiting our understanding of the disease and the implementation of cos...

  • Review
  • Open Access
26 Citations
14,617 Views
17 Pages

Marburg Virus Reverse Genetics Systems

  • Kristina Maria Schmidt and
  • Elke Mühlberger

22 June 2016

The highly pathogenic Marburg virus (MARV) is a member of the Filoviridae family and belongs to the group of nonsegmented negative-strand RNA viruses. Reverse genetics systems established for MARV have been used to study various aspects of the viral...

  • Article
  • Open Access
7 Citations
3,642 Views
17 Pages

Ebola Virus Activates IRE1α-Dependent XBP1u Splicing

  • Cornelius Rohde,
  • Sebastian Pfeiffer,
  • Sara Baumgart,
  • Stephan Becker and
  • Verena Krähling

30 December 2022

Ebola (EBOV) and Marburg virus (MARV) are highly pathogenic filoviruses that influence cellular signaling according to their own needs. MARV has been shown to regulate the IRE1α-dependent unfolded protein response (UPR) to ensure optimal virus...

  • Article
  • Open Access
1 Citations
3,055 Views
24 Pages

18 March 2024

The Marburg virus (MARV), the virus responsible for Marburg hemorrhagic fever (MHF), is considered a top-priority pathogen for vaccine development. Recent outbreaks in Equatorial Africa have highlighted the urgency of MARV because of its high fatalit...

  • Article
  • Open Access
1 Citations
1,739 Views
16 Pages

We performed whole genome sequencing (WGS) of 15 Palyam serogroup virus (PALV) strains isolated from cattle or Culicoides biting midges in Japan from 1984 to 2018. We found that the PALV strains consisted of Chuzan (Kasba) virus (CHUV), D‘Aguil...

  • Review
  • Open Access
16 Citations
3,866 Views
10 Pages

19 June 2023

Outbreaks of viral hemorrhagic fever caused by filoviruses have become more prevalent in recent years, with outbreaks of Ebola virus (EBOV), Sudan virus (SUDV), and Marburg virus (MARV) all occurring in 2022 and 2023. While licensed vaccines are now...

  • Article
  • Open Access
1,894 Views
16 Pages

25 October 2023

Vehicular ad hoc networks consist of self-organizing nodes using multi-hop wireless links for communication without any infrastructure support. Traditionally, ad hoc routing protocols use the minimum hop count for their routing metric since a smaller...

  • Review
  • Open Access
17 Citations
12,164 Views
38 Pages

Potential for Introduction of Bat-Borne Zoonotic Viruses into the EU: A Review

  • Robin R. L. Simons,
  • Paul Gale,
  • Verity Horigan,
  • Emma L. Snary and
  • Andrew C. Breed

16 May 2014

Bat-borne viruses can pose a serious threat to human health, with examples including Nipah virus (NiV) in Bangladesh and Malaysia, and Marburg virus (MARV) in Africa. To date, significant human outbreaks of such viruses have not been reported in the...

  • Article
  • Open Access
10 Citations
8,056 Views
17 Pages

Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials

  • Christopher L. Cooper,
  • Gavin Morrow,
  • Maoli Yuan,
  • John W. Coleman,
  • Fuxiang Hou,
  • Lucia Reiserova,
  • Shui L. Li,
  • Denise Wagner,
  • Alexei Carpov and
  • Christopher L. Parks
  • + 12 authors

21 September 2022

Vaccines are needed to disrupt or prevent continued outbreaks of filoviruses in humans across Western and Central Africa, including outbreaks of Marburg virus (MARV). As part of a filovirus vaccine product development plan, it is important to investi...

  • Communication
  • Open Access
13 Citations
7,355 Views
10 Pages

A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor

  • Života Selaković,
  • Dejan Opsenica,
  • Brett Eaton,
  • Cary Retterer,
  • Sina Bavari,
  • James C. Burnett,
  • Bogdan A. Šolaja and
  • Rekha G. Panchal

15 August 2012

Ebola (EBOV) and Marburg (MARV) filoviruses are highly infectious pathogens causing deadly hemorrhagic fever in humans and non-human primates. Promising vaccine candidates providing immunity against filoviruses have been reported. However, the sporad...

  • Article
  • Open Access
1,486 Views
18 Pages

Měnglà Virus VP40 Localizes to the Nucleus and Impedes the RIG-I Signaling Pathway

  • Joyce Sweeney Gibbons,
  • Naveen Thakur,
  • Emma Komers,
  • Olivia A. Vogel,
  • Poushali Chakraborty,
  • JoAnn M. Tufariello and
  • Christopher F. Basler

5 August 2025

Měnglà virus (MLAV) is a member of the genus Dianlovirus in the family Filoviridae, which also includes Ebola virus (EBOV) and Marburg virus (MARV). Whether MLAV poses a threat to human health is uncertain. However, the MLAV VP35 and VP40...

  • Article
  • Open Access
18 Citations
3,341 Views
18 Pages

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels

  • Machteld M. Tiemessen,
  • Laura Solforosi,
  • Liesbeth Dekking,
  • Dominika Czapska-Casey,
  • Jan Serroyen,
  • Nancy J. Sullivan,
  • Ariane Volkmann,
  • Maria Grazia Pau,
  • Benoit Callendret and
  • Ramon Roozendaal
  • + 3 authors

5 August 2022

The Marburg virus (MARV) and Sudan virus (SUDV) belong to the filovirus family. The sporadic human outbreaks occur mostly in Africa and are characterized by an aggressive disease course with high mortality. The first case of Marburg virus disease in...

  • Review
  • Open Access
28 Citations
8,905 Views
17 Pages

The Baboon (Papio spp.) as a Model of Human Ebola Virus Infection

  • Donna L. Perry,
  • Laura Bollinger and
  • Gary L.White

23 October 2012

Baboons are susceptible to natural Ebola virus (EBOV) infection and share 96% genetic homology with humans. Despite these characteristics, baboons have rarely been utilized as experimental models of human EBOV infection to evaluate the efficacy of pr...

  • Abstract
  • Open Access
1,625 Views
1 Page

Unique Features of Immunity within the Immunoglobulin Heavy Chain Locus of Egyptian Rousette Bats

  • Maggie L. Bartlett,
  • Peter A. Larson,
  • Mariano Sanchez-Lockhart and
  • Gustavo Palacios

Marburg virus (MARV) presents with a hemorrhagic fever in primates but asymptomatically in its known reservoir, the Egyptian rousette bat (Rousettus aegyptiacus, ERB). Understanding the biological mechanisms that explain these differential outcomes c...

  • Article
  • Open Access
20 Citations
8,881 Views
20 Pages

Validation of the Filovirus Plaque Assay for Use in Preclinical Studies

  • Amy C. Shurtleff,
  • Holly A. Bloomfield,
  • Shannon Mort,
  • Steven A. Orr,
  • Brian Audet,
  • Thomas Whitaker,
  • Michelle J. Richards and
  • Sina Bavari

21 April 2016

A plaque assay for quantitating filoviruses in virus stocks, prepared viral challenge inocula and samples from research animals has recently been fully characterized and standardized for use across multiple institutions performing Biosafety Level 4 (...

  • Article
  • Open Access
572 Views
13 Pages

Tetraspanin CD9 Is a Positive Regulator of Filovirus Egress

  • Loveleena K. Anand,
  • Marija A. Djurkovic,
  • Ariel Shepley-McTaggart,
  • Olena Shtanko and
  • Ronald N. Harty

13 January 2026

Filoviruses, including Ebola (EBOV) and Marburg (MARV) viruses, are zoonotic pathogens that cause severe hemorrhagic fever in humans, with mortality rates reaching up to 90%. Filovirus egress and spread are driven by the viral matrix protein VP40 and...

  • Article
  • Open Access
7 Citations
3,773 Views
27 Pages

29 July 2022

Since the discovery of the Marburg virus (MARV) in 1967 and Ebola virus (EBOV) in 1976, there have been over 40 reported outbreaks of filovirus disease with case fatality rates greater than 50%. This underscores the need for efficacious vaccines agai...

  • Review
  • Open Access
9 Citations
15,776 Views
21 Pages

21 January 2010

The members of the filoviruses are recognized as some of the most lethal viruses affecting human and non-human primates. The only two genera of the Filoviridae family, Marburg virus (MARV) and Ebola virus (EBOV), comprise the main etiologic agents of...

  • Systematic Review
  • Open Access
2,604 Views
28 Pages

Seroprevalence of Antibodies to Filoviruses with Outbreak Potential in Sub-Saharan Africa: A Systematic Review to Inform Vaccine Development and Deployment

  • Christopher S. Semancik,
  • Hilary S. Whitworth,
  • Matt A. Price,
  • Heejin Yun,
  • Thomas S. Postler,
  • Marija Zaric,
  • Andrew Kilianski,
  • Christopher L. Cooper,
  • Monica Kuteesa and
  • Suzanna C. Francis
  • + 3 authors

11 December 2024

Background/Objectives: Orthoebolaviruses and orthomarburgviruses are filoviruses that can cause viral hemorrhagic fever and significant morbidity and mortality in humans. The evaluation and deployment of vaccines to prevent and control Ebola and Marb...

  • Article
  • Open Access
1 Citations
4,775 Views
16 Pages

The Marburg virus (MARV) is a zoonotic pathogen that causes a high case fatality rate of up to 100% in humans. In response to Marburg virus disease (MVD) outbreaks in the Kagera region, an ecological investigation was initiated to map the population...

  • Review
  • Open Access
67 Citations
13,652 Views
16 Pages

Filoviral Immune Evasion Mechanisms

  • Parameshwaran Ramanan,
  • Reed S. Shabman,
  • Craig S. Brown,
  • Gaya K. Amarasinghe,
  • Christopher F. Basler and
  • Daisy W. Leung

7 September 2011

The Filoviridae family of viruses, which includes the genera Ebolavirus (EBOV) and Marburgvirus (MARV), causes severe and often times lethal hemorrhagic fever in humans. Filoviral infections are associated with ineffective innate antiviral responses...

  • Article
  • Open Access
44 Citations
7,449 Views
12 Pages

Marburg Virus Persistence on Fruit as a Plausible Route of Bat to Primate Filovirus Transmission

  • Brian R. Amman,
  • Amy J. Schuh,
  • César G. Albariño and
  • Jonathan S. Towner

30 November 2021

Marburg virus (MARV), the causative agent of Marburg virus disease, emerges sporadically in sub-Saharan Africa and is often fatal in humas. The natural reservoir for this zoonotic virus is the frugivorous Egyptian rousette bat (Rousettus aegyptiacus)...

  • Article
  • Open Access
10 Citations
4,081 Views
12 Pages

Receptor-Mediated Host Cell Preference of a Bat-Derived Filovirus, Lloviu Virus

  • Yoshihiro Takadate,
  • Rashid Manzoor,
  • Takeshi Saito,
  • Yurie Kida,
  • Junki Maruyama,
  • Tatsunari Kondoh,
  • Hiroko Miyamoto,
  • Hirohito Ogawa,
  • Masahiro Kajihara and
  • Ayato Takada
  • + 1 author

Lloviu virus (LLOV), a bat-derived filovirus that is phylogenetically distinct from human pathogenic filoviruses such as Ebola virus (EBOV) and Marburg virus (MARV), was discovered in Europe. However, since infectious LLOV has never been isolated, th...

  • Perspective
  • Open Access
1 Citations
2,569 Views
13 Pages

Rwandan National Reference Laboratory Championing Biosafety and Biosecurity While Leading the Response to Marburg Virus Outbreak in the Country

  • Emmanuel Edwar Siddig,
  • Ayman Ahmed,
  • Jean Claude Semuto Ngabonziza,
  • Isabelle Mukagatare and
  • Claude Mambo Muvunyi

The Marburg virus (MARV) is an extremely contagious zoonotic virus that leads to severe hemorrhagic fever in humans, with a fatality rate as high as 90%. It is known for causing nosocomial outbreaks in hospitals and laboratories globally. The recent...

of 2